About Pill Protect®

Joelle Michaud; Goranka Tanackovic

doi:10.4414/smw.2016.14392

Technical comment

Vol. 146 No. 4950 (2016)

About Pill Protect®

Joelle Michaud
Goranka Tanackovic

DOI: https://doi.org/10.4414/smw.2016.14392
Cite this as:: Swiss Med Wkly. 2016;146:w14392
Published: 04.12.2016

References

Bitzer J, Draths R, Yaron M. Méthodes contraceptives hormonales: risques d'usage et suggestions, 2012. MSD, WDMN-1035346-0000.
Swissmedic. Contraceptifs hormonaux et thromboembolies veineuses: annonces spontanées en Suisse et chiffres actualisés au 30.06.2016. Internet: https://www.swissmedic.ch/marktueberwachung/00135/00752/00753/index.html, accessed on August 8, 2016.
Blondon et al. Genetic testing to identify women at risk of venous thromboembolism with contraceptive pills: evidence- or hope-based tool? Swiss Med Wkly. 2016;146:w14321.

How to Cite

1.

Michaud J, Tanackovic G. About Pill Protect®. Swiss Med Wkly [Internet]. 2016 Dec. 4 [cited 2024 Dec. 4];146(4950):w14392. Available from: https://smw.ch/index.php/smw/article/view/2253

This work is licensed under a Creative Commons Attribution-NonCommercial-ShareAlike 4.0 International License.

[1] Bitzer J, Draths R, Yaron M. Méthodes contraceptives hormonales: risques d'usage et suggestions, 2012. MSD, WDMN-1035346-0000.

[2] Swissmedic. Contraceptifs hormonaux et thromboembolies veineuses: annonces spontanées en Suisse et chiffres actualisés au 30.06.2016. Internet: https://www.swissmedic.ch/marktueberwachung/00135/00752/00753/index.html, accessed on August 8, 2016.

[3] Blondon et al. Genetic testing to identify women at risk of venous thromboembolism with contraceptive pills: evidence- or hope-based tool? Swiss Med Wkly. 2016;146:w14321.